Javascript must be enabled to continue!
Achromobacter pneumonia in a patient with advanced COPD, a diagnostic challenge
View through CrossRef
Bacterial pneumonia causes significant morbidity and mortality especially in elderly and immunocompromised hosts. Achromobacter xylosoxidans denitrificans pneumonia is very rarely reported. However, the reported cases have been in patients who are either immunocompromised or have bronchiectasis. We hereby present a unique case of Achromobacter xylosoxidans denitrificans pneumonia in an immunocompetent patient with advanced chronic obstructive pulmonary disease (COPD). Our patient is a Caucasian male admitted with shortness of breath, fever and cough. Chest X-ray demonstrated right-sided infiltrates and he was treated with intravenous ceftriaxone and azithromycin. He was discharged home on oral amoxicillin-clavulanate 875–125 mg two times per day for a total of 7 days. Patient returned to emergency room after 5 weeks with persistent symptoms and chest X-ray revealed persistent right-sided infiltrate and sputum culture showed Achromobacter xylosoxidans denitrificans. The patient was started on oral levofloxacin 750 mg one time per day for 2 weeks with resolution of symptoms.
Title: Achromobacter pneumonia in a patient with advanced COPD, a diagnostic challenge
Description:
Bacterial pneumonia causes significant morbidity and mortality especially in elderly and immunocompromised hosts.
Achromobacter xylosoxidans denitrificans pneumonia is very rarely reported.
However, the reported cases have been in patients who are either immunocompromised or have bronchiectasis.
We hereby present a unique case of Achromobacter xylosoxidans denitrificans pneumonia in an immunocompetent patient with advanced chronic obstructive pulmonary disease (COPD).
Our patient is a Caucasian male admitted with shortness of breath, fever and cough.
Chest X-ray demonstrated right-sided infiltrates and he was treated with intravenous ceftriaxone and azithromycin.
He was discharged home on oral amoxicillin-clavulanate 875–125 mg two times per day for a total of 7 days.
Patient returned to emergency room after 5 weeks with persistent symptoms and chest X-ray revealed persistent right-sided infiltrate and sputum culture showed Achromobacter xylosoxidans denitrificans.
The patient was started on oral levofloxacin 750 mg one time per day for 2 weeks with resolution of symptoms.
Related Results
Innate immunity and its link to clinical outcomes in smokers with and without COPD
Innate immunity and its link to clinical outcomes in smokers with and without COPD
<p dir="ltr">Chronic obstructive pulmonary disease (COPD) is the fourth most common causes of death globally, affecting around ten percent of the adult population. Patients w...
Innate immunity and its link to clinical outcomes in smokers with and without COPD
Innate immunity and its link to clinical outcomes in smokers with and without COPD
<p dir="ltr">Chronic obstructive pulmonary disease (COPD) is the fourth most common causes of death globally, affecting around ten percent of the adult population. Patients w...
Prevalence and variability of siderophore production in the
Achromobacter
genus
Prevalence and variability of siderophore production in the
Achromobacter
genus
ABSTRACT
Achromobacter
spp. are opportunistic pathogens of environmental origin increasingly isolated in patients w...
Cancer development in COPD patients: retrospective analysis of the National Health Insurance Service-National Sample Cohort in Korea
Cancer development in COPD patients: retrospective analysis of the National Health Insurance Service-National Sample Cohort in Korea
Abstract
Background: COPD is a well-known risk factor for lung cancer, independent of smoking behavior. By investigating the retrospective National Health Insurance Service...
Cancer development in COPD patients: retrospective analysis of the National Health Insurance Service-National Sample Cohort in Korea
Cancer development in COPD patients: retrospective analysis of the National Health Insurance Service-National Sample Cohort in Korea
Abstract
Background: COPD is a well-known risk factor for lung cancer, independent of smoking behavior. By investigating the retrospective National Health Insurance Service...
Cancer development in COPD patients: retrospective analysis of the National Health Insurance Service-National Sample Cohort in Korea
Cancer development in COPD patients: retrospective analysis of the National Health Insurance Service-National Sample Cohort in Korea
Abstract
Background: COPD is a well-known risk factor for lung cancer, independent of smoking behavior. By investigating the retrospective National Health Insurance Service...
Irreversible Airflow Limitation in Elderly Adults with a History of Severe Childhood Asthma – COPD-A, COPD-C or?
Irreversible Airflow Limitation in Elderly Adults with a History of Severe Childhood Asthma – COPD-A, COPD-C or?
Abstract
Background
According to the GOLD 2023 strategy paper, classification of chronic obstructive pulmonary disease (COPD) may include distinct COPD types. We applied t...
Autonomy on Trial
Autonomy on Trial
Photo by CHUTTERSNAP on Unsplash
Abstract
This paper critically examines how US bioethics and health law conceptualize patient autonomy, contrasting the rights-based, individualist...

